Related Experiment Video
Updated: Jun 5, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Trends in management of phlegmasia cerulea dolens
Khamin Chinsakchai1, Kaj Ten Duis, Frans L Moll
1Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Insights
Phlegmasia cerulea dolens (PCD) is a severe venous thrombosis requiring prompt treatment. Current management strategies, often surgeon-dependent, show limited improvement despite minimally invasive advances.
Area of Science:
- Vascular Surgery
- Hematology
- Critical Care Medicine
Background:
- Phlegmasia cerulea dolens (PCD) is a rare, severe form of deep vein thrombosis.
- It carries a high risk of limb loss and mortality if not treated promptly.
- Established treatment guidelines are lacking, potentially limiting physician knowledge.
Purpose of the Study:
- To review clinical manifestations and diagnostic approaches for PCD.
- To identify factors influencing PCD outcomes.
- To summarize the evolution of PCD management and therapeutic options.
Main Methods:
- Systematic review of existing literature on Phlegmasia cerulea dolens.
- Analysis of clinical presentations, diagnostic strategies, and prognostic factors.
- Evaluation of historical and contemporary treatment modalities.
Main Results:
- Key predictors of PCD outcome include underlying malignancy, pulmonary embolism, and disease severity.
- Treatment options have seen minimal change over recent decades.
- Minimally invasive techniques have not demonstrated superior outcomes to traditional surgical thrombectomy.
- Treatment decisions often rely on PCD severity grading and surgeon expertise.
Conclusions:
- Effective management of Phlegmasia cerulea dolens necessitates early diagnosis and intervention.
- Further research is needed to establish clear treatment guidelines and improve outcomes.
- Current therapeutic approaches are largely surgeon-dependent and lack significant advancements.
Abstract:
Phlegmasia cerulea dolens (PCD) is a fulminant condition of acute massive venous thrombosis that may result in major amputation or death unless treated in an early phase. Guidelines for treatment are still not clearly documented. As a consequence, physicians might have limited knowledge of this potential life-threatening condition and its clinical course. Therefore, the purpose of this review was to analyze and summarize clinical manifestations and proposed diagnostic approach, factors that affect the outcome of PCD, and the evolution of management and therapeutic options. Underlying malignancy, pulmonary embolism, and PCD severity are the vital factors that predict the outcome of PCD. In the last decades, treatment options have remained largely unchanged. Published evidence shows that advances in minimally invasive techniques have not yet resulted in outcome improvements compared with traditional surgical thrombectomy. Treatment seems to depend on grading the severity of this condition and experience of the surgeon.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis IV: Nursing Management
Peripheral Artery Disease IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
